CHANGES OF SYSTEMIC FIBRINOLYTIC AND HEMOSTATIC PARAMETERS DURING LOCAL FIBRINOLYSIS WITH TISSUE-PLASMINOGEN ACTIVATOR (RT-PA)

被引：0

作者：

KLEIN, P

ROTH, FJ

RIEGER, H

POPOVCENIC, S

机构：

[1] UNIV BONN,AGGERTALKLIN ENGELSKIRCHEN,W-5300 BONN,GERMANY

[2] UNIV BONN,INST EXPTL HAMATOL,W-5300 BONN,GERMANY

来源：

VASA-JOURNAL OF VASCULAR DISEASES | 1992年 / 21卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

During the local fibrinolysis with rt-PA (2.5 mg/h) systemic plasminogen and alpha 2-antiplasmin activities slightly decrease, but the fibrinolytic system is compensated during the whole treatment. The d-dimer plasma levels increase dependently on the mass of thrombus. Despite the administration of high doses of heparin during the fibrinolysis thrombin is formed, measured as thrombin-antithrombin III complex (TAT).

引用

页码：249 / 252

页数：4

共 50 条

[1] Acute bandkeratopathy following intraocular fibrinolysis with recombinant tissue-plasminogen activator (rt-PA)
Althaus, C
Schelle, C
Sundmacher, R
KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 1996, 209 (05) : 318 - 321
[2] Recombinant tissue plasminogen activator (rt-PA) in fibrinolytic therapy
Werz, W
Werner, RG
JOURNAL OF BIOTECHNOLOGY, 1998, 61 (02) : 157 - 158
[3] SYSTEMIC FIBRINOLYTIC EFFECTS OF TISSUE PLASMINOGEN-ACTIVATOR (RT-PA) AND STREPTOKINASE (SK)
OCKELFORD, PA
SMITH, JM
NORRIS, RM
RIVERS, JT
WHITE, HD
ARTERIOSCLEROSIS, 1988, 8 (05): : A704 - A704
[4] ABSENCE OF SYSTEMIC FIBRINOLYSIS DURING CORONARY THROMBOLYSIS WITH RECOMBINANT HUMAN TYPE TISSUE PLASMINOGEN-ACTIVATOR (RT-PA)
GARABEDIAN, HD
GOLD, HK
LEINBACH, RC
YASUDA, T
GROSSBARD, EB
COLLEN, D
CIRCULATION, 1984, 70 (04) : 331 - 331
[5] Systemic thrombolysis with tissue plasminogen activator (rt-PA) in the elderly stroke patients
von Kummer, R
Bluhmki, E
Ringleb, P
Hacke, W
NERVENARZT, 1998, 69 (08): : 678 - 682
[6] RECOMBINANT TISSUE-PLASMINOGEN ACTIVATOR(rt-PA)IN ACUTE MYOCARDIAL INFARCTION IN THE CHINESEIN HONG KONG
Woo Kam Sang
Tse Kin Kee
Mak Yiu Kwong
Chung Hau Kwong
Tse Chun Yan
中华医学杂志(英文版), 1992, (05) : 374 - 378
[7] RECOMBINANT TISSUE-PLASMINOGEN ACTIVATOR(rt-PA)IN ACUTE MYOCARDIAL INFARCTION IN THE CHINESEIN HONG KONG
Woo Kam Sang
Tse Kin Kee
Mak Yiu Kwong
Chung Hau Kwong
Tse Chun Yan
CHINESEMEDICALJOURNAL, 1992, (05)
[8] SYSTEMIC FIBRINOLYTIC EFFECT OF PULSE-SPRAY THROMBOLYSIS WITH TISSUE-TYPE PLASMINOGEN-ACTIVATOR (RT-PA)
YUSUF, SW
WESTBY, J
WENHAM, PW
HOPKINSON, BR
MAKIN, GS
FIBRINOLYSIS, 1994, 8 : 108 - 110
[9] RECOMBINANT TISSUE-PLASMINOGEN ACTIVATOR (RT-PA) AS FIRST-LINE THERAPY FOR DECLOTTING OF HEMODIALYSIS ACCESS
ANDRIANI, M
DRAGO, G
BERNARDI, AM
DAPORTO, A
DELUCA, M
RIEGLER, P
BIASIA, F
PINZANI, A
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1995, 10 (09) : 1714 - 1719
[10] Difficulty in Applying Recombinant Tissue Plasminogen Activator (rt-PA)
Sugimura, Yusuke
Hoshino, Haruhiko
INTERNAL MEDICINE, 2016, 55 (08) : 1027 - 1028

← 1 2 3 4 5 →